Discontinuation report VESICARE
| Report ID | 274465 |
| Drug Identification Number | 02277263 |
| Brand name | VESICARE |
| Common or Proper name | Vesicare |
| Company Name | ASTELLAS PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SOLIFENACIN SUCCINATE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 Tablets |
| ATC code | G04BD |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-12-17 |
| Actual discontinuation date | 2025-12-17 |
| Remaining supply date | 2026-08-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 675 COCHRANE DRIVE, WEST TOWER, SUITE 650 MARKHAM, ONTARIO CANADA L3R 0B8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-17 | French | Compare |
| v1 | 2025-12-17 | English | Compare |
Showing 1 to 2 of 2